B. Hofner
Artificial Intelligence · 2010–2020
A researcher in the Science corpus: 4 papers; trusts 8 researchers and is trusted by 6 researchers here, as inferred from the citation graph.
Subfields
- Artificial Intelligence — 18 citations into it; #23,357 of 35,345 by trust here, #20,377 by citations
- Statistics and Probability — 18 citations into it; #8,578 of 12,932 by trust here, #5,294 by citations
- Statistical Learning Theory — 7 citations into it
- Evaluation & Benchmarks — 6 citations into it
- Optimization & Training — 5 citations into it
Whom B. Hofner trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Jerome H. Friedman
- Robert Tibshirani
- Peter Buhlmann
- David Ruppert
- Jun Yan
- Thomas Kneib
- Yoav Freund
- Ludwig Fahrmeir
Who trusts B. Hofner overall
Papers from B. Hofner's perspective
Ordered by how strongly the researchers B. Hofner trusts endorse each paper. Same corpus, a different order for every researcher.
- Regression Shrinkage and Selection via the Lasso
- Greedy function approximation: A gradient boosting machine.
- The Nature of Statistical Learning Theory
- The Elements of Statistical Learning: Data Mining, Inference, and Prediction
- Experiments with a New Boosting Algorithm
- Generalized Additive Models
- Boosting with the L2-loss: regression and classification
- PENALIZED STRUCTURED ADDITIVE REGRESSION FOR SPACE-TIME DATA: A BAYESIAN PERSPECTIVE
- Boosting with the L_2-Loss: Regression and Classification
- Survival Analysis: Techniques for Censored and Truncated Data
Their papers
- Model-based Boosting 2.0 (2010) — 201 citations
- Generalized additive models for location, scale and shape for high dimensional data—a flexible approach based on boosting (2012) — 178 citations
- OpenML: An R package to connect to the machine learning platform OpenML (2017) — 64 citations
- Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial. (2020)